Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
WBP1L pseudogene 10 (WBP1LP10) is a predicted pseudogene identified in the human genome. It is annotated in gene databases such as NCBI Gene with accession 106480326. Pseudogenes are non-functional genomic sequences related to known genes but lacking protein-coding potential[3]. There is no evidence in current literature or databases that WBP1LP10 is expressed, encodes a protein, has regulatory roles, or is implicated in disease or as a therapeutic target. It is not related to any clinically significant receptor, enzyme, transporter, or transcription factor, and is not considered in drug development or biomarker studies. The functional gene WBP1L is involved in hematopoietic stem cell regulation and leukemia, but the pseudogene WBP1LP10 itself is not referenced as biologically active in any setting relevant to therapeutics or diagnostics[1][2][5]. If you intended to refer to WBP1L (WW domain binding protein 1 like), which is involved in hematopoietic stem cell regulation and leukemia, then the target should be corrected to that gene/protein, not its pseudogene[1][2][5][6].
None.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on WBP1L pseudogene 10 (WBP1LP10).